MRVI — Maravai Lifesciences Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Maravai Lifesciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	551	632	575	322	217
Net Total Accounts Receivable
Net Total Receivables	118	147	55.7	38.5	25.5
Total Inventory
Prepaid Expenses
Total Current Assets	740	848	700	429	296
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	95.4	117	223	217	191
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	1,918	2,282	1,487	1,008	771
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	93.8	110	87.5	57	44.9
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	1,603	1,737	1,071	683	558
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	315	545	417	325	212
Total Liabilities & Shareholders' Equity	1,918	2,282	1,487	1,008	771
Total Common Shares Outstanding